We are thrilled to announce that Exploration of Drug Science (EDS) has been officially indexed in the Directory of Open Access Journals (DOAJ) on February 5, 2025! This significant milestone further strengthens the journal’s reputation and enhances its global accessibility.
The official website of EDS on DOAJ is https://doaj.org/toc/2836-7677.
DOAJ is a globally recognized database that indexes high-quality, peer-reviewed, open-access journals. Its criteria have become the gold standard for open-access publishing. Being indexed in DOAJ reaffirms our commitment to publishing high-quality research in drug science, ensuring that our articles are freely accessible and more discoverable by researchers, practitioners, and institutions worldwide.
We sincerely thank our Editor-in-Chief, Prof. Fernando Albericio, the editorial board, authors, reviewers, and readers for their invaluable support in achieving this recognition.
Looking ahead, we remain committed to providing free and professional publishing services, fostering impactful research, and expanding our influence in the field of drug science. We warmly invite researchers and scholars to submit their high-impact research, join our editorial and review teams, and contribute to advancing drug discovery and development.
For more information about EDS, please visit: https://www.explorationpub.com/Journals/eds.
Open Exploration Announces the 2024 Highly Cited Paper Award Winners
Open Exploration Journals Transition to Continuous Publishing Model
Exploration of Neuroprotective Therapy accepted for Scopus
Exploration of Foods and Foodomics Journal Achieves DOAJ Indexing
CiteScore 2023 of Three Open Exploration Journals